Biological determinants of radioresistance and their remediation in pancreatic cancer

Parthasarathy Seshacharyulu, Michael J. Baine, Joshua J. Souchek, Melanie Menning, Sukwinder Kaur, Ying Yan, Michel M Ouellette, Maneesh Jain, Chi Lin, Surinder Kumar Batra

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Despite recent advances in radiotherapy, a majority of patients diagnosed with pancreatic cancer (PC) do not achieve objective responses due to the existence of intrinsic and acquired radioresistance. Identification of molecular mechanisms that compromise the efficacy of radiation therapy and targeting these pathways is paramount for improving radiation response in PC patients. In this review, we have summarized molecular mechanisms associated with the radio-resistant phenotype of PC. Briefly, we discuss the reversible and irreversible biological consequences of radiotherapy, such as DNA damage and DNA repair, mechanisms of cancer cell survival and radiation-induced apoptosis following radiotherapy. We further describe various small molecule inhibitors and molecular targeting agents currently being tested in preclinical and clinical studies as potential radiosensitizers for PC. Notably, we draw attention towards the confounding effects of cancer stem cells, immune system, and the tumor microenvironment in the context of PC radioresistance and radiosensitization. Finally, we discuss the need for examining selective radioprotectors in light of the emerging evidence on radiation toxicity to non-target tissue associated with PC radiotherapy.

Original languageEnglish (US)
Pages (from-to)69-92
Number of pages24
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1868
Issue number1
DOIs
StatePublished - Aug 1 2017

Fingerprint

Pancreatic Neoplasms
Radiotherapy
Radiation
Tumor Microenvironment
Neoplastic Stem Cells
Radio
DNA Repair
DNA Damage
Immune System
Cell Survival
Apoptosis
Phenotype
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Biological determinants of radioresistance and their remediation in pancreatic cancer. / Seshacharyulu, Parthasarathy; Baine, Michael J.; Souchek, Joshua J.; Menning, Melanie; Kaur, Sukwinder; Yan, Ying; Ouellette, Michel M; Jain, Maneesh; Lin, Chi; Batra, Surinder Kumar.

In: Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1868, No. 1, 01.08.2017, p. 69-92.

Research output: Contribution to journalReview article

@article{72e3ba688fb74b7db3b5f9f1ae42cfcc,
title = "Biological determinants of radioresistance and their remediation in pancreatic cancer",
abstract = "Despite recent advances in radiotherapy, a majority of patients diagnosed with pancreatic cancer (PC) do not achieve objective responses due to the existence of intrinsic and acquired radioresistance. Identification of molecular mechanisms that compromise the efficacy of radiation therapy and targeting these pathways is paramount for improving radiation response in PC patients. In this review, we have summarized molecular mechanisms associated with the radio-resistant phenotype of PC. Briefly, we discuss the reversible and irreversible biological consequences of radiotherapy, such as DNA damage and DNA repair, mechanisms of cancer cell survival and radiation-induced apoptosis following radiotherapy. We further describe various small molecule inhibitors and molecular targeting agents currently being tested in preclinical and clinical studies as potential radiosensitizers for PC. Notably, we draw attention towards the confounding effects of cancer stem cells, immune system, and the tumor microenvironment in the context of PC radioresistance and radiosensitization. Finally, we discuss the need for examining selective radioprotectors in light of the emerging evidence on radiation toxicity to non-target tissue associated with PC radiotherapy.",
author = "Parthasarathy Seshacharyulu and Baine, {Michael J.} and Souchek, {Joshua J.} and Melanie Menning and Sukwinder Kaur and Ying Yan and Ouellette, {Michel M} and Maneesh Jain and Chi Lin and Batra, {Surinder Kumar}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.bbcan.2017.02.003",
language = "English (US)",
volume = "1868",
pages = "69--92",
journal = "Biochimica et Biophysica Acta - Reviews on Cancer",
issn = "0304-419X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Biological determinants of radioresistance and their remediation in pancreatic cancer

AU - Seshacharyulu, Parthasarathy

AU - Baine, Michael J.

AU - Souchek, Joshua J.

AU - Menning, Melanie

AU - Kaur, Sukwinder

AU - Yan, Ying

AU - Ouellette, Michel M

AU - Jain, Maneesh

AU - Lin, Chi

AU - Batra, Surinder Kumar

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Despite recent advances in radiotherapy, a majority of patients diagnosed with pancreatic cancer (PC) do not achieve objective responses due to the existence of intrinsic and acquired radioresistance. Identification of molecular mechanisms that compromise the efficacy of radiation therapy and targeting these pathways is paramount for improving radiation response in PC patients. In this review, we have summarized molecular mechanisms associated with the radio-resistant phenotype of PC. Briefly, we discuss the reversible and irreversible biological consequences of radiotherapy, such as DNA damage and DNA repair, mechanisms of cancer cell survival and radiation-induced apoptosis following radiotherapy. We further describe various small molecule inhibitors and molecular targeting agents currently being tested in preclinical and clinical studies as potential radiosensitizers for PC. Notably, we draw attention towards the confounding effects of cancer stem cells, immune system, and the tumor microenvironment in the context of PC radioresistance and radiosensitization. Finally, we discuss the need for examining selective radioprotectors in light of the emerging evidence on radiation toxicity to non-target tissue associated with PC radiotherapy.

AB - Despite recent advances in radiotherapy, a majority of patients diagnosed with pancreatic cancer (PC) do not achieve objective responses due to the existence of intrinsic and acquired radioresistance. Identification of molecular mechanisms that compromise the efficacy of radiation therapy and targeting these pathways is paramount for improving radiation response in PC patients. In this review, we have summarized molecular mechanisms associated with the radio-resistant phenotype of PC. Briefly, we discuss the reversible and irreversible biological consequences of radiotherapy, such as DNA damage and DNA repair, mechanisms of cancer cell survival and radiation-induced apoptosis following radiotherapy. We further describe various small molecule inhibitors and molecular targeting agents currently being tested in preclinical and clinical studies as potential radiosensitizers for PC. Notably, we draw attention towards the confounding effects of cancer stem cells, immune system, and the tumor microenvironment in the context of PC radioresistance and radiosensitization. Finally, we discuss the need for examining selective radioprotectors in light of the emerging evidence on radiation toxicity to non-target tissue associated with PC radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85014707248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014707248&partnerID=8YFLogxK

U2 - 10.1016/j.bbcan.2017.02.003

DO - 10.1016/j.bbcan.2017.02.003

M3 - Review article

C2 - 28249796

AN - SCOPUS:85014707248

VL - 1868

SP - 69

EP - 92

JO - Biochimica et Biophysica Acta - Reviews on Cancer

JF - Biochimica et Biophysica Acta - Reviews on Cancer

SN - 0304-419X

IS - 1

ER -